They need to amend page 18 and remove the reference to CSL 112 as a candidate product currently in phase III trials.
Just highlight and delete.
Ann: Shareholder Information Meetings, page-4
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$307.90 |
Change
-0.020(0.01%) |
Mkt cap ! $148.1B | |||
| Open | High | Low | Value | Volume |
| $307.40 | $307.90 | $304.87 | $133.8M | 435.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 863 | $307.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $307.92 | 211 | 1 |
View Market Depth
| Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
| CSL (ASX) Chart |